Moreover, CRISPR-based KO screening has identified that depletion of MIEF2 promoted oxaliplatin resistance in colorectal cancer through suppressing the mitochondrial apoptosis cascade in colorectal cancer organoids (Xie et al. 2022). The gene discussed is MIEF2; the disease is colorectal cancer.